The ASCO meeting I'm at right now is so busy that there really isn't time to write a new post (though I'm still "tweeting from the meeting"). Though the talk show hows just air re-runs of old shows when they're on vacation, I'm trying to continue to add new content to the website during this time (and it's about as far from a vacation as anyone has in Orlando).

Here's an interview I did with Dr. Suresh Ramalingam, medical oncologist and Director of the Thoracic Oncology Program at Winship Cancer Institute at Emory University. It covers the current status of initial treatment for advanced NSCLC, including controversies and shifting standards for first line and then the transition into maintenance therapy. There's also an associated slide set (as a pdf file), a transcript, and a link to the audio (mp3) version.

[powerpress]

ramalingam-podcast-figures-on-first-line-rx-and-maint2

ramalingam-first-line-and-maintenance-rx-transcript

Ramalingam First Line and Maintenance Rx for Adv NSCLC Audio Podcast